<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">3398</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"> http://dx.doi.org/10.31782/IJCRR.2021.13431</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>A Case Study on Management of Complex Renal Calculi (Mutrashmari) by Ayurvedic Formulation&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>SD</surname><given-names>Wairagade</given-names></name></contrib><contrib contrib-type="author"><name><surname>AV</surname><given-names>Nagrare</given-names></name></contrib><contrib contrib-type="author"><name><surname>T</surname><given-names>Wairagade</given-names></name></contrib><contrib contrib-type="author"><name><surname>K</surname><given-names>Umate</given-names></name></contrib><contrib contrib-type="author"><name><surname>Y</surname><given-names>Lamture</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>16</day><month>02</month><year>2021</year></pub-date><volume>)</volume><issue/><fpage>152</fpage><lpage>156</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Introduction: Kidney stone disease should be viewed as a systemic disorder, associated with hypertension, insulin resistance, chronic kidney disease and cardiovascular damage. Mutrashmari (Renal calculi/ Kidney stones) is one among the Ashtamahagada (eight fatal conditions) and is Kaphapradhan Tridoshaja Vyadhi. It is correlated with urolithiasis. The prevalence of symptomatic urolithiasis is approximately 10 per cent in men and 5 per cent in women. Many treatment modalities have been introduced in medical sciences, but it is very costly and even the recurrence of production of stone cannot be prevented. Objectives: To find out easily available, a cost-effective medicine to treat Mutrashmari. The available treatments options for prevention of stone recurrence can be divided into lifestyle interventions and pharmaceutical therapies. Case Presentation: In the first follow-up; the patient informed the stone was expelled out through urine, and he experienced moderate pain and disturbance in the urine flow on 30th day. The patient got moderate relief from pain in the abdomen and did not experience dysuria. Conclusion: Our present findings suggest that Chandraprabha Vati, Ayurvedic Formulation Tablet, Varunadi Kshaya is a safe and effective approach for the management of patients with renal stones.&#13;
</p></abstract><kwd-group><kwd>Renal calculi</kwd><kwd> Mutrashmari</kwd><kwd> Shaman Chikitsa</kwd><kwd> Ayurvedic formulation</kwd><kwd> Urolithiasis</kwd></kwd-group></article-meta></front></article>
